Huo TI - Search Results

1

Assessing liver dysfunction in cirrhosis: role of the model for end-stage liver disease and its derived systems.

Lee YH, Hsu CY, Huo TI. Lee YH, et al. Among authors: huo ti. J Chin Med Assoc. 2013 Aug;76(8):419-24. doi: 10.1016/j.jcma.2013.04.010. Epub 2013 Jun 5. J Chin Med Assoc. 2013. PMID: 23746532 Free article. Review.

2

Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study.

Huo TI, Wu JC, Lee PC, Chang FY, Lee SD. Huo TI, et al. Liver Int. 2004 Jun;24(3):210-5. doi: 10.1111/j.1478-3231.2004.00911.x. Liver Int. 2004. PMID: 15189271

3

Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment.

Huo TI, Wu JC, Lui WY, Huang YH, Lee PC, Chiang JH, Chang FY, Lee SD. Huo TI, et al. Am J Gastroenterol. 2004 Aug;99(8):1479-87. doi: 10.1111/j.1572-0241.2004.30024.x. Am J Gastroenterol. 2004. PMID: 15307864

4

Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.

Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Huang YH, Lee PC, Chang FY, Lee SD. Huo TI, et al. Liver Transpl. 2004 Dec;10(12):1507-13. doi: 10.1002/lt.20310. Liver Transpl. 2004. PMID: 15558587 Free article.

5

Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives.

Huo TI, Huang YH, Wu JC. Huo TI, et al. J Chin Med Assoc. 2005 Apr;68(4):155-9. doi: 10.1016/S1726-4901(09)70239-4. J Chin Med Assoc. 2005. PMID: 15850062 Free article. Review.

6

Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.

Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD. Huo TI, et al. J Hepatol. 2005 Jun;42(6):826-32. doi: 10.1016/j.jhep.2005.01.019. Epub 2005 Mar 31. J Hepatol. 2005. PMID: 15885353

7

Different model for end-stage liver disease score block distributions may have a variable ability for outcome prediction.

Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD. Huo TI, et al. Transplantation. 2005 Nov 27;80(10):1414-8. doi: 10.1097/01.tp.0000181164.19658.7a. Transplantation. 2005. PMID: 16340784

8

Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.

Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD. Huo TI, et al. Liver Transpl. 2006 Jan;12(1):65-71. doi: 10.1002/lt.20560. Liver Transpl. 2006. PMID: 16382473 Free article.

9

Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.

Huo TI, Lin HC, Lee FY, Hou MC, Lee PC, Wu JC, Chang FY, Lee SD. Huo TI, et al. Liver Int. 2006 Feb;26(1):55-61. doi: 10.1111/j.1478-3231.2005.01190.x. Liver Int. 2006. PMID: 16420510

10

Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy.

Huo TI, Huang YH, Lin HC, Wu JC, Chiang JH, Lee PC, Chang FY, Lee SD. Huo TI, et al. Am J Gastroenterol. 2006 May;101(5):975-82. doi: 10.1111/j.1572-0241.2006.00462.x. Am J Gastroenterol. 2006. PMID: 16573785

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters